Published in Women's Health Weekly, December 6th, 2001
The results of this study confirm previous findings that anakinra (IL-1ra), an inhibitor of interleukin-1, is effective in improving signs and symptoms and physical function of rheumatoid arthritis patients with active disease despite on-going methotrexate treatment. Additionally, anakinra was well tolerated with the most common adverse...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.